![2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F167467-2h-pyrido-32-b-14-oxazin-3-4h-one.webp&w=3840&q=75)
CAS 20348-09-8: 2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one
Formula:C7H6N2O2
InChI:InChI=1S/C7H6N2O2/c10-6-4-11-5-2-1-3-8-7(5)9-6/h1-3H,4H2,(H,8,9,10)
InChI key:InChIKey=ANHQLUBMNSSPBV-UHFFFAOYSA-N
SMILES:O=C1NC=2C(OC1)=CC=CN2
Synonyms:- 2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-one
- 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one
- NSC 122276
- 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one
- 2H-Pyrido[3,2-b][1,4]oxazin-3-one
- 4H-Pyrido[3,2-b][1,4]oxazin-3-one
- 2H,3H,4H-Pyrido[3,2-b][1,4]oxazin-3-one
Sort by
Found 4 products.
2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-one
CAS:Formula:C7H6N2O2Purity:97%Color and Shape:SolidMolecular weight:150.13472H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one
CAS:2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one is a guanylate cyclase activator that is used as an investigational agent in the treatment of thrombocytopenia. It has been shown to increase platelet production by activating soluble guanylyl cyclase and increasing cGMP levels. 2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one has also been shown to activate the immune system by stimulating T cells and B cells. This drug inhibits tyrosine kinases and may inhibit the proliferation of tumour cells.Formula:C7H6N2O2Purity:Min. 95%Molecular weight:150.13 g/molRef: 3D-FH76080
Discontinued product2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-one
CAS:2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-oneFormula:C7H6N2O2Purity:95%Color and Shape: faint brown/beige crystalline powderMolecular weight:150.13g/mol2H-Pyrido[3,2-b][1,4]oxazin-3(4H)-one
CAS:Purity:98.0%Color and Shape:Solid, Beige powderMolecular weight:150.13699340820312